FUNDAMENTALS · Fundamentals · US Healthcare

Ardent Health (ARDT) Fundamentals 2026 — P/E 10.9x, Revenue Analysis | SniperIQ

Ardent Health (ARDT) is a US-listed Healthcare company in Medical - Care Facilities with a market capitalization of

.5B, trading at
0.38 on the NYSE. This SniperIQ fundamentals page covers Ardent Health's valuation (P/E 10.9x, P/B 0.8x), profitability (net margin 2.1%), revenue ($6.3B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap
.5B
P/E (TTM)10.9x
Net Margin2.1%
Revenue (FY25)$6.3B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Ardent Health's market cap?

Ardent Health (ARDT) has a market capitalization of approximately

.5B, trading at
0.38 on the NYSE. Market cap moves with the live share price.

What is Ardent Health's P/E ratio?

Ardent Health's trailing twelve-month P/E ratio is 10.9x, with a price-to-book (P/B) of 0.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Ardent Health?

Ardent Health runs a net profit margin of 2.1%, a gross margin of 49.7%, and an operating margin of 9.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Ardent Health generate?

Ardent Health reported revenue of $6.3B for fiscal year 2025, with net income of

36M and earnings per share (EPS) of 0.96. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Ardent Health pay a dividend?

Ardent Health does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Ardent Health financially healthy?

Ardent Health carries a debt-to-equity ratio of 1.32x and a current ratio of 2.12x, with a market beta of 0.75. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Ardent Health a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Ardent Health (ARDT) the key facts are: market cap

.5B, P/E 10.9x, revenue $6.3B, 52-week range 7.71-15.48. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Ardent Health's full fundamentals live

Get Ardent Health's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: AdaptHealth (AHCO) fundamentals · Amylyx Pharmaceuticals (AMLX) fundamentals · Trulieve Cannabis (TRLV) fundamentals · Inspire Medical Systems (INSP) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons